Evidence map›Paper›PMID 37900181›Full record

ReviewFrontiers in genetics2023

Single-cell analysis technologies for cancer research: from tumor-specific single cell discovery to cancer therapy.

Siyuan Chen, Weibo Jiang, Yanhui Du, Manshi Yang, Yihan Pan, Huan Li, Mengying Cui

Abstract readReview
In one paragraph

Review in Frontiers in genetics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Review
  2. Isolation and Sequencing of Single Circulating Tumor Cells.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Siyuan ChenDepartment of Hepatobiliary and Pancreatic Surgery, The Second Hospital of Jilin University, Changchun, China.
Weibo JiangDepartment of Orthopaedic, The Second Hospital of Jilin University, Changchun, China.
Yanhui DuDepartment of Orthopaedics, Jilin Province People's Hospital, Changchun, China.
Manshi YangDepartment of Hepatobiliary and Pancreatic Surgery, The Second Hospital of Jilin University, Changchun, China.
Yihan PanDepartment of Hepatobiliary and Pancreatic Surgery, The Second Hospital of Jilin University, Changchun, China.
Huan LiDepartment of Hepatobiliary and Pancreatic Surgery, The Second Hospital of Jilin University, Changchun, China.
Mengying CuiDepartment of Hepatobiliary and Pancreatic Surgery, The Second Hospital of Jilin University, Changchun, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Single-cell sequencing (SCS) technology is changing our understanding of cellular components, functions, and interactions across organisms, because of its inherent advantage of avoiding noise resulting from genotypic and phenotypic heterogeneity across numerous samples. By directly and individually measuring multiple molecular characteristics of thousands to millions of single cells, SCS technology can characterize multiple cell types and uncover the mechanisms of gene regulatory networks, the dynamics of transcription, and the functional state of proteomic profiling. In this context, we conducted systematic research on SCS techniques, including the fundamental concepts, procedural steps, and applications of scDNA, scRNA, scATAC, scCITE, and scSNARE methods, focusing on the unique clinical advantages of SCS, particularly in cancer therapy. We have explored challenging but critical areas such as circulating tumor cells (CTCs), lineage tracing, tumor heterogeneity, drug resistance, and tumor immunotherapy. Despite challenges in managing and analyzing the large amounts of data that result from SCS, this technique is expected to reveal new horizons in cancer research. This review aims to emphasize the key role of SCS in cancer research and promote the application of single-cell technologies to cancer therapy.

Indexed as

circulating tumor cells (CTCs)lineage tracingsingle-cell sequencing (SCS)tumor heterogeneitytumor immunotherapy

Identifiers

PMID37900181
PMCPMC10602688

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.